Ascorbic acid Terminated Phase 1 Trials for Gliomas / Glioblastomas Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02833701Bevacizumab and Ascorbic Acid in Patients Treating With Recurrent High Grade Glioma